Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2023 Oct 13;30(11):1583. doi: 10.1038/s41417-023-00677-0

Retraction Note: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting

Yichu Nie 1,2, Fenglan Feng 3, Wei Luo 1, Andrew J Sanders 4, Yidi Zhang 2, Jiaming Liang 3, Cheng Chen 3, Weineng Feng 1, Weiquan Gu 1, Weiping Liao 5, Wei Wang 5, Jinfeng Chen 6, Lijian Zhang 6, Wen G Jiang 4, Jin Li 3,
PMCID: PMC10645582  PMID: 37833404

Retraction to: Cancer Gene Therapy 10.1038/s41417-022-00459-0, published online 30 March 2022

The Editor-in-Chief has retracted this article. After publication irregularities were noted in multiple figures, specifically:

In Figure 2E there is overlap between the images in the 2% CSE for A549 and HCI-N292.

Figure 4F the Rac1 band overlaps with the CREB band in figure 5C.

Furthermore, the authors were unable to provide the raw images of the blots published in this study. the The Editor-in-Chief has therefore lost confidence in the results presented in this article.

Yichu Nie does not agree to this retraction. Fenglan Feng, Wei Luo, Andrew J. Sanders, Yidi Zhang, Jiaming Liang, Cheng Chen, Weineng Feng, Weiquan Gu, Weiping Liao, Wei Wang, Jinfeng Chen, Lijian Zhang, Wen G. Jiang and Jin Li have not responded to any correspondence from the editor about this retraction.


Articles from Cancer Gene Therapy are provided here courtesy of Nature Publishing Group

RESOURCES